Claims data show regorafenib is prescribed earlier than guidelines advise for a good share of patients with advanced GIST, with dosing also varying widely.
|Articles|October 27, 2011
Cost Control Incentives for Doctors, Hospitals Don't Affect Patient Outcomes when Quality Variables Are Implemented
Advertisement
Findings from a 4-year study suggest that pay for performance (P4P) incentive programs help reduce costs without impacting complications and death rates from major surgeries when quality care variables are implemented.
The researchers, formed from a group of hospitals in New York City, presented their findings at the 2011 Annual Clinical Congress of the American College of Surgeons.
Read the full story at:
Sources: American College of Surgeons; Newswise
Advertisement
Related to this article
Oral GLP-1s, Medicare access, and lingering weight bias are reshaping obesity care, says NYU Langone's Holly Lofton, MD.
Activated memory B cells were already enriched at treatment end in the 5 of 21 patients who later cleared HBsAg
Specialty pharmacy leaders will gather in National Harbor for inSPire2026, tackling cell and gene therapy access, AI, and high-cost drug pricing.
ERS spotlights AI lung disease detection; employer cancer benefits; outpatient CAR T; tafasitamab response similar across races; HFpEF missed at referral.
Each additional hour of nightly CPAP use was associated with 13% lower all-cause mortality risk in a French cohort of adults with sleep apnea.
A 20-year Danish registry study found higher antidepressant and anxiolytic use among women with endometriosis, both before and after diagnosis.
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
Advertisement
Advertisement
Trending on AJMC
1
Delayed Dupilumab Raises Asthma Costs 32%: Nicola Hanania, MD
2
A Patient-Centered Reconstruction of 340B in Oncology: Transparency, Equity, and Site-of-Care Accountability
3
FDA Expands Finerenone Approval to CKD Associated With Type 1 Diabetes
4
Oral GLP-1s, Medicare Bridge Reshape Obesity Care: Holly Lofton, MD
5